Citius Oncology CTOR
NASDAQ CTOR
$1.05 +0.02 (+1.94%)
At close: Sep 29, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Receivables - Net (2025 - 2026)

Updated

Citius Oncology (CTOR) recorded Receivables - Net of $686,235 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 36.4% from the prior quarter.

Analysis

Citius Oncology (CTOR) Receivables - Net (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Citius Oncology 108.93 Mn 108.93 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 686,235.00
Mar 31, 2026 1.08 Mn
Dec 31, 2025 4.05 Mn
API Access

Citius Oncology Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CTOR&period=max&api_key=YOUR_API_KEY